162 related articles for article (PubMed ID: 10511398)
1. Pharmacokinetics of antibiotics in burn patients.
Weinbren MJ
J Antimicrob Chemother; 1999 Sep; 44(3):319-27. PubMed ID: 10511398
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of antibiotics in burn patients].
Lesne-Hulin A; Bourget P; Carsin H
Therapie; 1995; 50(6):575-86. PubMed ID: 8745959
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
[TBL] [Abstract][Full Text] [Related]
4. Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations.
Lindsay CA; Bosso JA
Clin Pharmacokinet; 1993 Jun; 24(6):496-506. PubMed ID: 8513651
[TBL] [Abstract][Full Text] [Related]
5. [Intracellular pharmacokinetics and pharmacodynamics of antibiotics].
Tulkens PM
Rev Pneumol Clin; 1996; 52 Suppl 2():S51-5. PubMed ID: 9033918
[No Abstract] [Full Text] [Related]
6. Pharmacokinetics of systemically administered antibiotics in patients with thermal injury.
Boucher BA; Kuhl DA; Hickerson WL
Clin Infect Dis; 1992 Feb; 14(2):458-63. PubMed ID: 1554831
[TBL] [Abstract][Full Text] [Related]
7. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.
Blanchet B; Jullien V; Vinsonneau C; Tod M
Clin Pharmacokinet; 2008; 47(10):635-54. PubMed ID: 18783295
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the pharmacokinetics of linezolid in burn and non-burn rabbits.
Ma JL; Gao L; Li X; Chu WL; Feng YQ; Wang XQ; Zhang QZ
Eur J Drug Metab Pharmacokinet; 2015 Sep; 40(3):355-61. PubMed ID: 24924311
[TBL] [Abstract][Full Text] [Related]
9. Role of pharmacokinetics and pharmacodynamics: does the dose matter?
MacGowan AP
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S238-9. PubMed ID: 11524725
[TBL] [Abstract][Full Text] [Related]
10. Adequacy of a hospital-wide standard dose of 7mg/kg bodyweight gentamicin sufficient to achieve an adequate prophylactic maximum serum concentration (C
Borra LC; Bosch TM; van Baar ME; Dokter J; Oen IM; Ruijgrok EJ
Burns; 2016 Dec; 42(8):1819-1824. PubMed ID: 27595454
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage.
Meyers BR; Wilkinson P
Clin Pharmacokinet; 1989 Dec; 17(6):385-95. PubMed ID: 2689039
[TBL] [Abstract][Full Text] [Related]
12. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
[TBL] [Abstract][Full Text] [Related]
13. Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections.
Tulkens PM
Scand J Infect Dis Suppl; 1990; 74():209-17. PubMed ID: 2097709
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of pefloxacin in burn patients].
Potel G; Meignier M; Touzé MD; Montay G; Drugeon HB; Baron D
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):777-80. PubMed ID: 3309814
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial dosing in obese patients.
Wurtz R; Itokazu G; Rodvold K
Clin Infect Dis; 1997 Jul; 25(1):112-8. PubMed ID: 9243045
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin pharmacokinetics in patients with severe burn injuries.
Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
[TBL] [Abstract][Full Text] [Related]
17. Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review.
Steele AN; Grimsrud KN; Sen S; Palmieri TL; Greenhalgh DG; Tran NK
J Burn Care Res; 2015; 36(3):e194-211. PubMed ID: 25942648
[TBL] [Abstract][Full Text] [Related]
18. [Resistance of gram-negative bacteria to beta-lactams, aminoglycosides and quinolones].
Schumacher H; Thomsen VF
Ugeskr Laeger; 1994 Oct; 156(42):6185-90. PubMed ID: 7998354
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations for the indication-justified application of antibiotics. 2. Aminoglycosides, quinolones, tetracyclines].
Briedigkeit H; Halle E
Z Arztl Fortbild (Jena); 1991 Aug; 85(16):743-6. PubMed ID: 1949996
[No Abstract] [Full Text] [Related]
20. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
